On January 4, Greenview Life (300642.SZ) announced that the company plans to establish a wholly-owned subsidiary TELLGEN SINGAPORE PTE in Singapore through foreign direct investment. LTD. (Chinese name: Toujing Life Technology (Singapore) Co., Ltd.) (Tentative name, specific name is based on the final approved name, hereinafter referred to as “Singapore subsidiary”), mainly engaged in R&D, production, sales and technical services of in vitro diagnostic reagents and instruments. The investment amount is 2 million US dollars, and the funding source is its own capital.
透景生命(300642.SZ)：拟200万美元设立新加坡全资子公司
Vision Life (300642.SZ): Plans to establish a wholly-owned subsidiary in Singapore for 2 million US dollars
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.